Crossref
Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia
Experimed · 2022
DOI: 10.26650/experimed.1191622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Fatih Akboğa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Akboğa, F., Hindilerden, F., Gültürk, E., Hindilerden, İ. Y., Yılmaz, A., Deniz, G., & Gelmez, M. (2022). Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia. Experimed. https://doi.org/10.26650/experimed.1191622
Vancouver
Akboğa F, Hindilerden F, Gültürk E, Hindilerden İY, Yılmaz A, Deniz G, et al. Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia. Experimed. 2022. doi:10.26650/experimed.1191622
BibTeX
@article{Akboa2022,
author = {Akboğa, Fatih and Hindilerden, Fehmi and Gültürk, Emine and Hindilerden, İpek Yönal and Yılmaz, Abdullah and Deniz, Günnur and Gelmez, Metin},
title = {Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia},
journal = {Experimed},
year = {2022},
doi = {10.26650/experimed.1191622}
}
EUVIMED